ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225 | +11150.0% | 29,017 | +7397.9% | 0.00% | – |
| Q1 2023 | $2 | -91.7% | 387 | -90.8% | 0.00% | – |
| Q4 2022 | $24 | -99.9% | 4,184 | -58.7% | 0.00% | – |
| Q3 2022 | $32,000 | -13.5% | 10,121 | +22.0% | 0.00% | – |
| Q2 2022 | $37,000 | +311.1% | 8,297 | +348.0% | 0.00% | – |
| Q1 2022 | $9,000 | +350.0% | 1,852 | +1496.6% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | – | 116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |